Reviva Pharma RVPH down big.
Reviva Pharma RVPH down big on massive volume, to find out why take a look at this technical analysis by our Alexander Goldman down below
Reviva Pharmaceuticals RVPH Company Summary
Company Name: Reviva Pharmaceuticals Holdings, Inc.
Ticker: RVPH
Exchange: NASDAQ
Website: https://ir.revivapharma.com/
Reviva Pharmaceutical Company Summary
Reviva Pharma RVPH is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.
Also, Reviva’s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva’s pipeline currently includes two drug candidates, RP5063 (brilaroxazine) and RP1208.
Therefore, Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and RP1208 in the United States (U.S.), Europe, and several other countries.
Why did RVPH go down?
Jan. 10th 2021
Reviva Pharma RVPH announced today the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with Phase 3 clinical investigation of its lead candidate, brilaroxazine, a novel serotonin and dopamine receptor modulator for the treatment of schizophrenia.
RVPH 3 Month Chart
RVPH 1 Day Chart
RVPH Technical Analysis
Reviva Pharmaceutical is looking bad, real bad. Don’t put it on your watchlist. It’s bearish all the way around.
Pluristem Therapeutics PSTI Collaboration
Pluristem Therapeutics PSTI signs a massive collaboration deal. Also, the stock looks great. Take a look below.
Pluristem Therapeutics PSTI Company Summary
Company Name: Pluristem Therapeutics Inc.
Ticker: PSTI
Exchange: NASDAQ
Website: https://www.pluristem.com/
Pluristem Therapeutics Company Summary
Pluristem is pushing the boundaries of science and engineering to create cell-based products for commercial use. The Company’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation.
Moreover, pluristem Therapeutics’ sources its therapeutic cells from the placenta, an ethically accepted and potent source.
The Company’s manufacturing platform is a patented and validated state-of-the-art 3D cell expansion system. Pluristem’s method is uniquely accurate, cost-effective, and consistent from batch to batch.
Why did PSTI go up?
Jan. 10th 2021
Announced the launch of an innovative collaboration to develop, manufacture and commercialize cultured cell-based products for the food industry.
Therefore, the collaboration started with the incorporation of a new company (“NewCo”), that will receive exclusive, global, royalty bearing licensing rights to use Pluristem’s proprietary technology, intellectual property and knowhow, to be used in the field of cultured meat.
PSTI 3 Month Chart
PSTI 1 Day Chart
PSTI Technical Analysis
The $1.87 PPS for Pluristem Therapeutics PSTI is important before I would consider the trade. However, this stock is looking great! It gapped up big and pulled back for a minute and consolidated all day with a bullish lean.
Pluristem Therapeutics PSTI is possibly a winner, but I wouldn’t expect big things, probably sub 50% gains in the next few weeks.
Zynga ZNGA purchased for $12B
Zynga ZNGA purchased for $12B by Take-Two Interactive. ZNGA gaps up 46% with heavy trading volume this morning. Let’s take a closer look at Zynga.
Zynga Inc. ZNGA Company Summary
Company Name: Zynga Inc.
Ticker: ZNGA
Exchange: NASDAQ
Website: www.zynga.com
[thrive_leads id=’9825′]
Zynga Inc. ZNGA Company Summary
Zynga ZNGA is a global leader in interactive entertainment with a mission to connect the world through games.
Therefore with it’s massive global reach in more than 175 countries and regions, Zynga has a diverse portfolio of popular game franchises that have been downloaded more than four billion times. Just on mobile including CSR Racing™, Empires & Puzzles™, FarmVille™, Golf Rival, Hair Challenge™, Harry Potter: Puzzles & Spells™, High Heels!, Dragons!™, Merge Magic!™, Toon Blast™, Toy Blast™, Words With Friends™ and Zynga Poker™.
With Chartboost, a leading mobile advertising and monetization platform, Zynga is an industry-leading next-generation platform with the ability to optimize programmatic advertising and yields at scale.
Founded in 2007, Zynga is headquartered in California with locations in North America, Europe and Asia.
Why did ZNGA go up over 40% overnight?
Jan. 10th 2021
Take-Two to acquire all the outstanding shares of Zynga for a total value of $9.861 per share – $3.50 in cash and $6.361 in shares of Take-Two common stock, implying an enterprise value of $12.7 billion.
Transaction represents a 64% premium to Zynga’s closing share price on January 7, 2022.
Establishes Take-Two as one of the largest publishers of mobile games, the fastest-growing segment of the interactive entertainment industry.
Unifies highly complementary businesses, including Take-Two’s best-in-class portfolio of console and PC games and Zynga’s industry-leading mobile franchises.
Creates one of the largest publicly traded interactive entertainment companies in the world, with $6.1 billion in trailing twelve-month pro-forma Net Bookings for the period ended September 30, 2021.
Consequently, Transaction expected to deliver approximately $100 million of annual cost synergies within the first two years after closing, and more than $500 million of annual Net Bookings opportunities over time.
Take-Two TTWO Company Summary
Company Name: Take-Two Interactive Software, Inc.
Ticker: TTWO
Exchange: NASDAQ
Website: https://www.take2games.com/
Zynga Inc. ZNGA Company Summary
Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading developer, publisher, and marketer of interactive entertainment for consumers around the globe.
We develop and publish products principally through Rockstar Games, 2K, Private Division, and T2 Mobile Games.
Take-Two TTWO products are designed for console systems, personal computers, and mobile, including smartphones and tablets.
Also, they deliver through physical retail, digital download, online platforms, and cloud streaming services. Take-Two TTWO common stock trades on NASDAQ under the symbol TTWO.
ZNGA 3 Month Chart
Zynga ZNGA 1 Day Chart
ZNGA Technical Analysis
After the announcement that Take-Two TTWO was acquiring Zynga Inc. ZNGA the stock gapped up with heavy trading volume by over 40%! Meanwhile TTWO suffers in PPS with a massive sell off.
ZNGA is shockingly consolidating after the massive run with a slight pullback. This is a good sign. Therefore, I would like to see it break $8.70 then $8.76 before I would take a position because normally there will be a massive sell off after a huge gap up like this.
[thrive_leads id=’9825′]